COMP <GO>
MET vs BRK-B // RSI-14 & 200D SMA MOMENTUM
MetLife Inc. (NYSE) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: MET 8
— BRK-B 6
▲ RSI-14 & 200D SMA MOMENTUM LEADER: BRK-B
LAST: $100.02 (-0.80%) • MKT CAP: $64.08B
rsi-technicals
53.1
LAST: $542.49 (+0.10%) • MKT CAP: $1.16T
rsi-technicals
66.8
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MET VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MET | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.60% | 11.47% | -9.87 | BRK-B | /roic <GO> |
| EV/EBITDA & P/E Valuation | 55.0x | 9.7x | +45.32 | BRK-B | /valuation <GO> |
| Free Cash Flow Yield | 22.00% | 2.09% | +19.91 | MET | /fcf-yield <GO> |
| Operating Margin | 75.00% | 27.80% | +47.20 | MET | /operating-margins <GO> |
| Net Profit Margin | 68.00% | 22.30% | +45.70 | MET | /net-margins <GO> |
| Revenue Growth (YoY) | 8.50% | 3.93% | +4.57 | MET | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.36% | 0.00% | +2.36 | MET | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 2.85 | -2.40 | BRK-B | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 4/9 | +3.00 | MET | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 3.55% | +3.85 | BRK-B | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 53.1 | 66.8 | -13.76 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.16 | 0.61 | +0.55 | MET | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.8x | 24.3x | -5.54 | MET | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $64.08B | $1.16T | -$1.10T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MET REV | BRK-B REV | MET GROSS % | BRK-B GROSS % | MET FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.44B | $371.44B | 44.0% | — | $16.98B | $25.04B |
| FY 2024 | $2.25B | $371.43B | 44.0% | — | $14.50B | $11.62B |
| FY 2023 | $2.23B | $364.48B | 44.0% | — | $13.62B | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MET // BETA 1.16
BRK-B // BETA 0.61